| Detected | Trial | Change |
|---|---|---|
| 2026-08-04 | NCT06594094 An Open-label, Multidose Dose-escalation Study to Understand the Safety of CRISPR… |
Sponsor refiled this as active, not recruiting (was completed) |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 1/2 | |||
| NCT05906953 | Safety and Efficacy Trial of HG004 for Leber Congenital Amaurosis Related to Rpe65 Gene… | Leber Congenital Amaurosis | Recruiting |
| Phase 1 | |||
| NCT06623279 | Open-laBel Dose-escalation Study for CRISPR/cas13- Rna TargetInG THerapy for the… | Neovascular Age-Related Macular Degeneration (nAMD) | Not Yet Recruiting |
| Early Phase 1 | |||
| NCT06031727 | CRISPR/cas13-medIated RNA TarGeting THerapy for the Treatment of Neovascular Age-related… | Neovascular Age-related Macular Degeneration(nAMD) | Recruiting |
| NCT07063251 | An Clinical Study Evaluating the Safety, Tolerability, and efficAcy of HG005 in StaRgardT… | Stargardt Disease Type 1 (STGD1) | Recruiting |
| NCT06594094 | An Open-label, Multidose Dose-escalation Study to Understand the Safety of CRISPR… | Duchenne Muscular Dystrophin (DMD) | Active, Not Recruiting |
| Not specified | |||
| NCT06615206 | A First-in-Human Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of a… | MECP2 Duplication Syndrome | Recruiting |